Persistent Asset Partners »

Cue Biopharma shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.7k 33k 0.23

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Vanguard Capital Management
Lion Point Capital
Geode Capital Management
Vanguard Fiduciary Trust
Robertson Stephens Wealth Management
BlackRock
Texas Capital Bank Wealth Management Services
Angeles Wealth Management
Advisory Research
Stifel Financial
Renaissance Technologies
Bank of America Corporation

View all funds holding Cue Biopharma